Status:
COMPLETED
Relationship of Ochratoxin A to Upper Urologic Cancers
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Transitional Cell Carcinoma
Renal Cell Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This pilot study will explore the relationship of Ochratoxin A (OTA) levels in patients with upper tract transitional cell (TCC), renal cell, and testicular cancers by measuring levels of OTA in serum...
Detailed Description
Ochratoxin A (OTA, a ubiquitous mycotoxin) is a common food contaminant that enters the food chain from plants such as cereals. OTA can be inhaled or ingested and livestock and humans feeding on OTA c...
Eligibility Criteria
Inclusion
- Study Group
- Informed consent
- Must have resectable non-metastatic upper tract transitional cell carcinoma, renal cell carcinoma, or testicular carcinoma.
- Willingness to be followed for survival data.
- Control Group
- Informed consent
- No history of carcinoma
Exclusion
- Metastatic upper tract transitional cell carcinoma, renal cell carcinoma, or testicular carcinoma.
- Any other ongoing or previous malignancy other than basal or squamous cell skin cancer.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00216801
Start Date
September 1 2005
End Date
April 1 2007
Last Update
January 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Josephs Health Care
London, Ontario, Canada